Drug prioritization identifies panobinostat as a tailored treatment element for patients with metastatic hepatoblastoma
Abstract Background Patients with metastatic hepatoblastoma are treated with severely toxic first-line chemotherapies in combination with surgery. Yet, inadequate response of lung metastases to neo-adjuvant chemotherapy still compromises patient outcomes making new treatment strategies, tailored to...
I tiakina i:
| Ngā kaituhi matua: | , , , , , , , , , , , , , |
|---|---|
| Hōputu: | Artigo |
| Reo: | Inglês |
| I whakaputaina: |
BMC
2024-11-01
|
| Rangatū: | Journal of Experimental & Clinical Cancer Research |
| Ngā marau: | |
| Urunga tuihono: | https://doi.org/10.1186/s13046-024-03221-6 |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|